Dorit Arlt

1.1k total citations
17 papers, 823 citations indexed

About

Dorit Arlt is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Dorit Arlt has authored 17 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Dorit Arlt's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Advanced Biosensing Techniques and Applications (4 papers) and Gene expression and cancer classification (3 papers). Dorit Arlt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Advanced Biosensing Techniques and Applications (4 papers) and Gene expression and cancer classification (3 papers). Dorit Arlt collaborates with scholars based in Germany, United Kingdom and Austria. Dorit Arlt's co-authors include Stefan Wiemann, Annemarie Poustka, Özgür Şahin, Ulrike Korf, Tim Beißbarth, Christian Löbke, Meher Majety, Holger Fröhlich, Ingo Schupp and Sara Burmester and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Dorit Arlt

17 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorit Arlt Germany 14 673 243 119 85 59 17 823
Philip G. Febbo United States 8 644 1.0× 265 1.1× 215 1.8× 77 0.9× 30 0.5× 15 1.0k
Steven Kregel United States 14 616 0.9× 256 1.1× 254 2.1× 80 0.9× 29 0.5× 23 1.1k
Kübra Karagoz United States 14 496 0.7× 250 1.0× 117 1.0× 46 0.5× 60 1.0× 25 685
Tea Vallenius Finland 14 789 1.2× 125 0.5× 228 1.9× 22 0.3× 33 0.6× 15 1.2k
Joan Grindlay United Kingdom 11 1.1k 1.6× 128 0.5× 154 1.3× 21 0.2× 37 0.6× 12 1.4k
Reid T. Powell United States 12 604 0.9× 174 0.7× 157 1.3× 56 0.7× 21 0.4× 38 949
Petra Massoner Austria 16 441 0.7× 246 1.0× 178 1.5× 43 0.5× 11 0.2× 22 728
PuiYee Chan United States 10 550 0.8× 62 0.3× 88 0.7× 86 1.0× 33 0.6× 11 998
Frederick S. Vizeacoumar Canada 17 603 0.9× 154 0.6× 226 1.9× 27 0.3× 25 0.4× 51 912
Christophe Frémin France 15 650 1.0× 107 0.4× 201 1.7× 23 0.3× 29 0.5× 17 1.0k

Countries citing papers authored by Dorit Arlt

Since Specialization
Citations

This map shows the geographic impact of Dorit Arlt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorit Arlt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorit Arlt more than expected).

Fields of papers citing papers by Dorit Arlt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorit Arlt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorit Arlt. The network helps show where Dorit Arlt may publish in the future.

Co-authorship network of co-authors of Dorit Arlt

This figure shows the co-authorship network connecting the top 25 collaborators of Dorit Arlt. A scholar is included among the top collaborators of Dorit Arlt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorit Arlt. Dorit Arlt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wagner, Steve, et al.. (2015). mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer. PLoS ONE. 10(2). e0117818–e0117818. 35 indexed citations
2.
Ćuk, Katarina, Manuela Zucknick, Joerg Heil, et al.. (2012). Circulating microRNAs in plasma as early detection markers for breast cancer. International Journal of Cancer. 132(7). 1602–1612. 211 indexed citations
3.
Korf, Ulrike, Christian Löbke, Özgür Şahin, et al.. (2009). Reverse‐phase protein arrays for application‐orientated cancer research. PROTEOMICS - CLINICAL APPLICATIONS. 3(10). 1140–1150. 6 indexed citations
4.
Şahin, Özgür, Holger Fröhlich, Christian Löbke, et al.. (2009). Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance. BMC Systems Biology. 3(1). 1–1. 247 indexed citations
5.
Fröhlich, Holger, Özgür Şahin, Dorit Arlt, Christian Bender, & Tim Beißbarth. (2009). Deterministic Effects Propagation Networks for reconstructing protein signaling networks from multiple interventions. BMC Bioinformatics. 10(1). 322–322. 18 indexed citations
6.
Löbke, Christian, Mark Laible, Markus Ruschhaupt, et al.. (2008). Contact spotting of protein microarrays coupled with spike‐in of normalizer protein permits time‐resolved analysis of ERBB receptor signaling. PROTEOMICS. 8(8). 1586–1594. 12 indexed citations
7.
Hahne, Florian, Alexander Mehrle, Dorit Arlt, et al.. (2008). Extending pathways based on gene lists using InterPro domain signatures. BMC Bioinformatics. 9(1). 3–3. 15 indexed citations
8.
Şahin, Özgür, Holger Sültmann, Sandra Blaszkiewicz, et al.. (2007). Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene. 27(9). 1320–1326. 43 indexed citations
9.
Hahne, Florian, Christian Schmidt, Meher Majety, et al.. (2007). High-Throughput Flow Cytometry–Based Assay to Identify Apoptosis-Inducing Proteins. SLAS DISCOVERY. 12(4). 510–520. 4 indexed citations
10.
Şahin, Özgür, Christian Löbke, Ulrike Korf, et al.. (2007). Combinatorial RNAi for quantitative protein network analysis. Proceedings of the National Academy of Sciences. 104(16). 6579–6584. 49 indexed citations
11.
Hahne, Florian, Dorit Arlt, Meher Majety, et al.. (2006). Statistical methods and software for the analysis of highthroughput reverse genetic assays using flow cytometry readouts. Genome biology. 7(8). R77–R77. 16 indexed citations
12.
Buneß, Andreas, Christian Schmidt, Fritz Klimek, et al.. (2005). Systematic comparison of surface coatings for protein microarrays. PROTEOMICS. 5(18). 4705–4712. 39 indexed citations
13.
Wiemann, Stefan, Dorit Arlt, Wolfgang Huber, et al.. (2004). From ORFeome to Biology: A Functional Genomics Pipeline. Genome Research. 14(10b). 2136–2144. 32 indexed citations
14.
Bläker, Michael, Andreas de Weerth, Mareike Tometten, et al.. (2002). Expression of the cholecystokinin 2-receptor in normal human thyroid gland and medullary thyroid carcinoma. European Journal of Endocrinology. 146(1). 89–96. 23 indexed citations
15.
Hennige, Anita M., Reiner Lammers, Wolfgang Höppner, et al.. (2001). Inhibition of Ret Oncogene Activity by the Protein Tyrosine Phosphatase SHP1. Endocrinology. 142(10). 4441–4447. 30 indexed citations
16.
Arlt, Dorit, et al.. (2000). A novel type of mutation in the cysteine rich domain of the RET receptor causes ligand independent activation. Oncogene. 19(30). 3445–3448. 17 indexed citations
17.
Hennige, Anita M., Reiner Lammers, Dorit Arlt, et al.. (2000). Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells. Molecular and Cellular Endocrinology. 167(1-2). 69–76. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026